People: ev3 Inc. (EVVV.O)

EVVV.O on Nasdaq

14.22USD
9 Feb 2010
Price Change (% chg)

$0.08 (+0.57%)
Prev Close
$14.22
Open
--
Day's High
$14.44
Day's Low
$14.07
Volume
377,071
Avg. Vol
615,295
52-wk High
$15.69
52-wk Low
$5.05

view people for:

Summary

Name Age Since Current Position
Levangie, Daniel 58 2008 Chairman of the Board
Palmisano, Robert 64 2008 President, Chief Executive Officer, Director
McCormick, Shawn 44 2009 Chief Financial Officer, Senior Vice President
Girin, Pascal 49 2010 Chief Operating Officer, Executive Vice President
Enxing Seng, Stacy 44 2008 Executive Vice President; President- U.S. Peripheral Vascular
Klemz, Kevin 47 2007 Senior Vice President, Secretary, Chief Legal Officer
Morrison, Gregory 45 2007 Senior Vice President - Human Resources
Mowry, David 46 2010 Senior Vice President, President - Worldwide Neurovascular
Tracy, Julie 47 2008 Senior Vice President, Chief Communications Officer
Timbie, Thomas 51 2005 Director
Emmitt, Richard 64 2005 Director
Kohrs, Douglas 51 2005 Director
Weatherman, Elizabeth 49 2005 Director
Bakewell, John 47 2006 Director
Child, Jeffrey 49 2007 Director
Miclot, John 49 2008 Director
» Insider Trading

Biographies

Name Description
Levangie, Daniel Daniel J. Levangie has served as Chairman of the Board of ev3 Inc. since April 6, 2008 and as one of directors since February 2007. From July 2006 to October 2007, Mr. Levangie served as the President, Surgical Products Division, and as an Executive Vice President and director of Cytyc Corporation, a provider of surgical and diagnostic products targeting women’s health and cancer, since July 2006. Prior to July 2006, Mr. Levangie held several positions with Cytyc, including Executive Vice President and Chief Operating Officer from July 2000 to June 2002, Chief Executive Officer and President of Cytyc Health Corporation from July 2002 to December 2003 and Executive Vice President and Chief Commercial Officer from January 2004 to June 2006. Mr. Levangie is also a member of the board of directors of Dune Medical Devices Ltd. and HyperMed, Inc., both privately held medical device companies.
Palmisano, Robert Robert J. Palmisano has served as President and Chief Executive Officer and as one of directors of ev3. Inc.since April 2008. Mr. Palmisano served as President and Chief Executive Officer of IntraLase Corp., a company engaged in the design, development and manufacture of laser products for vision correction, from April 2003 to April 2007, when IntraLase was acquired by Advanced Medical Optics, Inc. From April 2001 to April 2003, Mr. Palmisano was the President, Chief Executive Officer and a director of MacroChem Corporation, a development stage pharmaceutical corporation. From April 1997 to January 2001 Mr. Palmisano served as President and Chief Executive Officer and a director of Summit Autonomous, Inc., a global medical products company that was acquired by Alcon, Inc. in October 2000. Prior to 1997, Mr. Palmisano held various executive positions with Bausch & Lomb Incorporated, a global eye care company. Mr. Palmisano earned his B.A. in Political Science from Providence College. Mr. Palmisano serves on the boards of directors of Advanced Medical Optics, Inc. and Osteotech, Inc., both publicly held companies, and Songbird Hearing, Inc., a privately held company.
McCormick, Shawn Mr. Shawn T. McCormick has been appointed as the Chief Financial Officer, Senior Vice President of ev3 Inc. on January 19, 2009. He brings more than 15 years of experience in the medical device industry to ev3. He most recently served as Vice President, Corporate Development at Medtronic, Inc. where he was responsible for Medtronic’s worldwide business development activities and previously had served in key corporate and divisional financial leadership roles within the Medtronic organization. Mr. McCormick joined Medtronic in July 1992 and held various finance positions during his tenure. From May 2008 to January 2009, he served as Vice President, Corporate Development of Medtronic. From July 2007 to May 2008, he served as Vice President, Corporate Technology and New Ventures of Medtronic. From July 2002 to July 2007, he was Vice President, Finance for Medtronic’s Spinal, Biologics and Navigation business. Prior to that, Mr. McCormick held various other positions with Medtronic, including Corporate Development Director, Principal Corporate Development Associate, Manager, Financial Analysis, Senior Financial Analyst and Senior Auditor. Prior to joining Medtronic, he spent almost four years with the public accounting firm KPMG Peat Marwick. Mr. McCormick earned his M.B.A. from the University of Minnesota’s Carlson School of Management and his B.S. in Accounting from Arizona State University. He is a Certified Public Accountant.
Girin, Pascal Pascal E. R. Girin has been appointed as Executive Vice President and Chief Operating Officer of ev3 Inc. effective January 1, 2010. He has global operating responsibility for ev3's peripheral vascular, neurovascular and international businesses. Mr. Girin was Executive Vice President and President - Worldwide Neurovascular and International of ev3 Inc. since July2008. He was Senior Vice President of ev3 Inc since August 2007 and President, International since July 2005. Mr. Girin previously served as General Manager, Europe from September 2003 to July 2005. From September 1998 to August 2003, Mr. Girin served in various capacities at BioScience Europe Baxter Healthcare Corporation, most recently as Vice President. Mr. Girin received an Engineering Education at the French Ecole des Mines.
Enxing Seng, Stacy Stacy Enxing Seng has served as Executive Vice President and President, U.S. Peripheral Vascular of ev3 Inc. since December 2008. Prior to December 2008, Ms. Enxing Seng served as President, FoxHollow Technologies Division since October 2007, Senior Vice President since August 2007 and President, Peripheral Vascular Division since March 2005. Ms. Enxing Seng also previously served as Vice President, Marketing and New Business Development. Ms. Enxing Seng has served in various positions since April 2001. From March 1999 to April 2001, she served as Vice President of Marketing for the cardiology division at Boston Scientific/SCIMED. Ms. Enxing Seng has a Bachelor of Arts in Public Policy from Michigan State University and a Master of Business Administration from Harvard University.
Klemz, Kevin Kevin M. Klemz is Senior Vice President, Secretary, Chief Legal Officer of ev3 Inc. He has served as Senior Vice President of ev3 Inc since August 2007 and Secretary and Chief Legal Officer since January 2007. Prior to joining ev3, Mr. Klemz was a partner in the law firm Oppenheimer Wolff & Donnelly LLP where he was a corporate lawyer for over 20 years. Mr. Klemz has a Bachelor of Arts in Business Administration from Hamline University and a Juris Doctorate from William Mitchell College of Law.
Morrison, Gregory Gregory Morrison has served as Senior Vice President, Human Resources of ev3 Inc. since August 2007 and from March 2002 to August 2007 as Vice President, Human Resources. From March 1999 to February 2002, Mr. Morrison served as Vice President of Organizational Effectiveness for Thomson Legal & Regulatory, a division of The Thomson Corporation that provides integrated information solutions to legal, tax, accounting, intellectual property, compliance, business and government professionals. Mr. Morrison has a Bachelor of Arts in English and Communications from North Adams State College and a Master of Arts in Corporate Communications from Fairfield University.
Mowry, David David H. Mowry has been appointed as Senior Vice President and President, Worldwide Neurovascular of ev3 Inc. effective January 1, 2010. He has global responsibility for ev3's neurovascular business. Mr. Mowry had served as Senior Vice President, Strategic and Corporate Operations of ev3 Inc. since July 2008 and from October 2007 to July 2008, served as Senior Vice President, Corporate Manufacturing. Prior to October 2007, Mr. Mowry served as Vice President of Operations for ev3 Neurovascular since November 2006. From February 2004 to November 2006, Mr. Mowry served as Vice President of Operations and Logistics at the Zimmer Spine division of Zimmer Holdings Inc., a reconstructive and spinal implants, trauma and related orthopaedic surgical products company. Prior to Zimmer, Mr. Mowry was the President and Chief Operating Officer of HeartStent Corp., a medical device company. Mr. Mowry is a graduate of the United States Military Academy in West Point, New York with a degree in Engineering and Mathematics.
Tracy, Julie Julie D. Tracy has served as Senior Vice President and Chief Communications Officer of ev3 Inc. since January 2008. From March 2007 to November 2007, Ms. Tracy served as Vice President, Chief Communications Officer of Kyphon Inc., a medical device company that was purchased by Medtronic, Inc. in November 2007. From April 2005 to March 2007, Ms. Tracy served as Vice President, Investor Relations and Corporate Marketing of Kyphon Inc. From January 2003 to April 2005, Ms. Tracy served as Vice President of Marketing at Kyphon Inc. Prior to joining Kyphon Inc., Ms. Tracy held senior level positions in marketing, business development and reimbursement at Thoratec Corporation from January 1998 to January 2003. Ms. Tracy has a Bachelor of Science in Business Administration from the University of Southern California and a Master of Business Administration from Pepperdine University.
Timbie, Thomas Thomas E. Timbie has served as one of Directors of ev3 Inc. since June 2005. Mr. Timbie served as a Vice President of ev3 from April 2005 until June 2005 and as ev3’s Interim Chief Financial Officer from January 2005 until April 2005. Mr. Timbie was a member of the board of managers of ev3 LLC from March 2004. Since 2000, Mr. Timbie has been the President of Timbie & Company, LLC, a financial and management consulting firm that he founded. During 2000, Mr. Timbie was the Interim Vice President and Chief Financial Officer of e-dr. Network, Inc., and from 1996 to 1999 he was the Vice President and Chief Financial Officer of Xomed Surgical Products, Inc. Mr. Timbie currently serves on the board of directors of American Medical Systems Holdings, Inc., a publicly held company, and Acclarent, Inc., a privately held medical device company.
Emmitt, Richard Richard B. Emmitt has served as one of Directors of ev3 Inc. since June 2005. Mr. Emmitt was a member of the board of managers of ev3 LLC from August 2003 through the date of the merger of ev3 LLC with and into ev3 in June 2005. Since 1989, Mr. Emmitt has been a General Partner of The Vertical Group, L.P., an investment management and venture capital firm focused on the medical device industry. Mr. Emmitt currently serves on the board of directors of American Medical Systems Holdings, Inc., a publicly held company, as well as BioSET, Inc., ENTrigue Surgical, Inc., Galil Medical, Inc., Incumed, Inc., Tepha, Inc. and Tornier B.V. (Dutch), all privately held companies.
Kohrs, Douglas Douglas W. Kohrs is a Director of ev3 Inc. since 2005. He currently serves as President and Chief Executive Officer of Tornier B.V., a privately held global orthopedic company, a position he has held since July 2006. Mr. Kohrs served as Chief Executive Officer of American Medical Systems Holdings, Inc. from April 1999 until January 2005. He served on the board of directors of American Medical Systems Holdings from 1999 to May 2006, and served as chairman of the board from March 2004 to May 2006. Mr. Kohrs currently serves as a director of Tornier B.V. and The Institute for Health Technology Studies (InHealth), a not-for-profit medical device research organization.
Weatherman, Elizabeth Elizabeth H. Weatherman has served as one of Directors of ev3 Inc. since June 2005. Ms. Weatherman was a member of the board of managers of ev3 LLC from August 2003 through the date of the merger of ev3 LLC with and into ev3 in June 2005. Ms. Weatherman is a Managing Director of Warburg Pincus LLC and a member of the firm’s Executive Management Group. Ms. Weatherman joined Warburg Pincus’ health care group in 1988 and is currently responsible for the firm’s medical device investment activities. Ms. Weatherman currently serves on the board of directors of Bausch & Lomb, Inc., Bacchus Vascular, Inc. and Tornier B.V. (Dutch), all privately held companies.
Bakewell, John John K. Bakewell has served as one of Directors of ev3 Inc. since April 2006. Mr. Bakewell currently serves as Executive Vice President and Chief Financial Officer of Wright Medical Group, Inc., a publicly held orthopaedic medical device company, a position he has held since December 2000. From July 1998 until December 2000, Mr. Bakewell served as Chief Financial Officer and Vice President of Finance and Administration with Altra Energy Technologies, Inc., a software and e-commerce solutions provider to the energy industry. From May 1993 to July 1998, Mr. Bakewell held the position of Vice President of Finance and Administration and Chief Financial Officer of Cyberonics, Inc., a publicly-held manufacturer of medical devices for the treatment of epilepsy and other neurological disorders. From October 1990 to May 1993, Mr. Bakewell served as Chief Financial Officer of ZEOS International Ltd., a publicly-held manufacturer and direct marketer of personal computers and related products. Mr. Bakewell currently serves on the board of directors of Keystone Dental, Inc., a privately held dental implant medical device company.
Child, Jeffrey Jeffrey B. Child has served as one of Directors of ev3 Inc. since October 2007 when he was elected to board of directors in connection with merger with FoxHollow Technologies, Inc. Mr. Child has served as Chief Financial Officer of a family office of an unaffiliated third party since July 2004. From February 1999 through June 2003, Mr. Child served as a Managing Director, U.S. Equity Capital Markets at Banc of America Securities LLC. Prior to that time, he served as a Managing Director in the Healthcare Group at Banc of America Securities. Mr. Child currently serves on the board of directors of AMERIGROUP Corporation, a multi-state managed healthcare company. Mr. Child also serves as a Trustee of the Menlo Park City School District Board of Education.
Miclot, John Mr. John Miclot is Director of ev3 Inc. He currently serves as President and Chief Executive Officer of CCS Medical, Inc., a privately held provider of home healthcare products, such as insulin pumps, incontinence products and respiratory equipment, a position he has held since November 2008. Prior to joining CCS Medical, Inc., Mr. Miclot served as Chief Executive Officer of Phillips Home Healthcare Solutions since March 2008, when Phillips acquired Respironics, Inc., a provider of sleep and respiratory products. From December 2003 to March 2008, Mr. Miclot served as President and Chief Executive Officer of Respironics, Inc. Prior to that position, Mr. Miclot served in various positions at Respironics, Inc. from 1998 to 2003, including Chief Strategic Officer and President of the Homecare Division. His previous employer, Healthdyne Technologies, Inc., a medical device company, was acquired by Respironics, Inc. in 1998. Mr. Miclot served in various positions at Healthdyne Technologies, Inc., including Senior Vice President, Sales and Marketing, from 1995 to 1998. He began his career at DeRoyal Industries, Inc. and Baxter International Inc. Mr. Miclot is a director of American Textiles Inc., Pittsburgh Zoo & PPG Aquarium, Burger King Cancer Caring Center, Allegheny Conference on Community Development, Washington & Jefferson College and the American Association for Homecare, all private companies, and is a director of Wright Medical Group, Inc., a public company.

Insider Trading

Name Shares Traded Price
MORRISON GREGORY 717 $0.00
MCCORMICK SHAWN 967 $0.00
KLEMZ KEVIN M 845 $0.00
WALL BRETT 893 $0.00
PALMISANO ROBERT J 3,401 $0.00
ENXING SENG STACY 1,060 $0.00
PALMISANO ROBERT J 2,041 $0.00
TRACY JULIE D 714 $0.00
EMMITT RICHARD B 100,000 $14.47
EMMITT RICHARD B 100,000 $14.20
EMMITT RICHARD B 100,000 $14.95
EMMITT RICHARD B 95,538 $14.03
EMMITT RICHARD B 100,000 $14.71
EMMITT RICHARD B 100,000 $15.21
EMMITT RICHARD B 262 $13.95
EMMITT RICHARD B 4,200 $13.95
GIRIN PASCAL E R 25,941 $0.00
MOWRY DAVID H 13,712 $0.00
EMMITT RICHARD B 55,044 $13.45
GIRIN PASCAL E R 503 $13.00
MOWRY DAVID H 100 $12.33
WALL BRETT 77 $12.29
TRACY JULIE D 6,739 $12.16
MCCORMICK SHAWN 5,280 $12.16
KLEMZ KEVIN M 110 $12.33
» Full list on Insider Trading
view people for: